Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Institutional Investors Showing Interest in Dental Implants BY ANDREW VAHRADIAN, NOVEMBER 30, 2012

Thomas Straumann, the Vice Chairman of the dental-implant manufacturer, Straumann Holding, sold a 10% stake in the company to the Government of Singapore Investment Corporation (GSIC), citing that he needed to meet other financial obligations due to the “prevailing weak economic environment”.

The sale reduces Mr. Straumann’s stake to 17% and increases the Singaporean sovereign-wealth fund’s holding to 14%, making the fund second-largest shareholder in the company.

The filing discloses that 1.52 million shares were sold for CHF 150 million ($162 million), implying a price of CHF 98.45 ($106.40) a share, which represents a 6.7% discount to the closing price on November 23.

Mr. Straumann, the grandson of the company’s founder, stated that Straumann Holding remained his core investment and that he fully intends to continue contributing to the company's long term direction. He has agreed to a one-year lock-up period during which he will not be able to further reduce his stake.

GSIC's investment in Straumann Holding is the second instance in recent months, in which an institutional investor has taken a significant share in the company, further demonstrating the long-term value institutional investors see in the dental implant industry. In August, Sprucegrove Investment Management acquired a 3% ownership stake in the company.

Email this to a colleague: